Zivo Bioscience Inc (QB) (ZIVO) News

LOL Weasel,

Some been picking up ZIVOW lately.
22000 purchase at avg price ~.39 during lunch and 2500 still bid at .35.

Interesting in my book ..... someone been buying them over the past week+. Roughly 22000 last week too .... wonder if that was a flip trade as a some of that happened in the .24 range.

Amigo Mike

Yep, big spread little spread doesn't matter until volume.

LOL...both the 8.10 bid and 8.15 offer disappear shortly after I post this. 🤣🤣🤣

We'll call that, Exhibit A. 😏

Gwinner- I hate to break it to you, but nothing about this company can currently be taken seriously...including the price action. It's all fictitious games.

Based on current price, simply put a large bid/ask below and above, respectively, that is unlikely to get hit given the volume is so putrid...therein creating the mirage that there is a set range/market. Reality is, it's all shenanigans. Case in point this morning, 8.15 offer...yet someone puts a bid at 8.10 rather than just hitting the offer. It's a measly $5.00 difference for the 100 share lot showing, so if that person(s) were serious...hitting the offer versus waiting on the bid is immaterial.

Unless/until we see real, consistent volume for several days...anything else means nada.

Again, same as it ever was...

Crazy wide spread today...healthy BID price at 7.60

Weazel,

💯💯💯💯💯

Same shit .... different year. Common sense is to bring in industry people to help facilitate the business. But we know that doesn't apply to ZIVO.

Amigo Mike

As I have stated numerous times, a few people control vast majority of shares and the controlling interest is only becoming more concentrated. Now that he is on the board, he will get the ridiculous number of free shares the other board members received. This is a public company in name only at this point.

Mike, don't you know that if you keep doing the same thing(s) over and over again...you'll get different outcomes. 😐️🤦

This is the reason it is so hard to have confidence in this company. Everything is the same as it ever was...

Welp,

Yaldoo officially appointed as Director of ZIVO today.

Another in long line of headscratching moves by ZIVO ....... IMO.

HOW ABOUT A RECENTLY RETIRE ANIMAL PHARMA EXECUTIVE OR VENTURE GUY IN THE NATURAL INGREDIENTS OR NEUTRACEUTICAL SPACE. GEEZUS.

I realize that he's probably done more monetarily for ZIVO than anyone but ..... just read the resume .... brings nothing to the table in any business ZIVO might hope to be in ...... AND .... his initially getting involved with ZIVO had contingency of Dahl being CEO who was kept around probaly 6-8 years longer than he should have been. Yaldoo's had a seat in the boardroom all these years so wired into what's happening.

But IMO, just doesn't make any sense to me.

Amigo Mike

Someone been nibbling at ZIVOW of late.

Interesting .... dunno if meaningful or not but haven't been expecting to see much action on that given the exercise price is $33 now. Of course a deal with global animal pharma could run those sharply upward and offer high leverage ...... assuming stock price launches. Cheap option really with just under 2 years remaining on it.

ZIVO the stock ..... frankly surprised it has not bled. It's basically flat for a couple months now hanging around $8 save the occasional drop/rise due to wide spreads. As we've discussed there's basically little to no float on this.

Currently a bidder for 2600 shares at $7.60 which is more volume than what's been trading for entire days of late. That area seems to be getting solid support still.

I'm still sitting tight on swing.
I want to see update on algae production.
I want to see update or any indication whether there is more than 1 global animal pharma involved with the coccidiosis candidate.
I want to see indication of MONEY needs as I'm sure that cash is running low again. Ideally animal pharma getting involved would like to see part of deal include purchase of shares from ZIVO for funding .... and OWNERSHIP ...... meaning fully invested in the process AND door open to acquisition.
I would also like to see some other tests done with the algae as an ingredient against cholesterol, sports recovery, etc ...... Simple shit ... not a ton of money. They have GRAS designation ..... no excuses to be able to make some claims on some easy stuff.

Amigo Mike

It's one random market maker playing with price...likely passing shares back and forth between themselves. Especially when the spread is this big.

Weazel, what is the significance that GTSM is first on BID/ASK?

Looking at a daily chart, if $7 becomes heavy..barring the unexpected...ZIVO appears to be starting its 'typical' slow death bleed into end of year as ALL VOLUME from 1/22/24 forward will be underwater.

Think 'they' know it too?? Check out that bid stack...lol. Granted, it's a puny number of 'shown' shares (no way to know if size is hidden unless those bids are hit)...but nevertheless...it's not a coincidence the stack is at this level.



PS- ALWAYS GTSM positioning themselves to be the first mm listed on both sides. Peculiar, indeed.

The only reason I can see why they retain a highly compensated CFO is to get this back to NASDAQ assuming positive results and money from partner. Otherwise makes no sense why they keep this guy and give him million dollar stock awards.

At this point, you are correct...that is literally the only way they can raise money moving forward if needed (ridiculously cheap shares via PP). However, even that needs some type of promise of an exit for the purchaser(s) to get "something" out of it, even if by means of selling those acquired shares...as otherwise it's just pissing money away to the new buyer when you have $1-$2.50 spreads and zero consistent volume.

This all feels like one last ditch effort for the grand slam, sale of company to me. While I know Amigo mentions the possibilities of other verticals (and they certainly do have them)...I'm just not sure the folks in charge wanna hassle or stick around for that given how long this has been. Seems like a show me the money, here's the keys to the car and be done situation here. JMO. We'll see how it shapes up.

Ideally we'll see consistent volume "suddenly" appear at some point over the next month to give an opportunity to position, but given the last 3-4 months...not counting on it. I still have my pittance of shares from last December for now.

“ Impossible to trade or position.”

Those owning vast majority of the stock and controlling the board do not care. If ZIVO needs more money, the buy cheap shares in PP.

This is where not being listed on an exchange and being on OTC is a hindrance...as it limits the volume potential outside of major news imo.


As suspected...

Total 💤💤💤-fest.

1299 shares on news day. 260 shares y'day. 0 shares thus far today.

OTC is not what it used to be back in the WGHL/HEPI days. Since listed small caps have become major plays daily, OTC is an afterthought (or maybe even a no-thought?). So, here we are...stuck in a no-mans-land purgatory of $1-$2.50 spreads and no volume. Impossible to trade or position.

No reason ZIVO is not making deals with other partners to pay for testing for other verticals such as canine while the 1,789 chicken test is completed. Should be plenty of supply for testing and hopefully highly paid scientists on payroll developed SOPs. Time to walk and chew gum.

Nice to see some ZIVO news...

Agreed,

Cannot build a position with the spread as wide as it is and the movement either way if someone sniffs it.

Happy to see it funded by a major pharma ..... but I'd like to know if it is the same pharma as before .... or is it another pharma getting into the fray ..... and if it is another pharma ..... is there a competition brewing .... or did other pharma drop from the picture. I would think that to be a valuable piece of info.

My impression is the original pharma .... who actually botched the original test ..... was continuing to talk to ZIVO all this time. So is it still them or someone else??? Can't tell from the PR. The original pharma I would think has all the data. This test is a little different and some different variations that I think are certainly worthy of testing but at same time, the data from prior tests is what it is ... and was performed under real world 42 day grow cycle conditions.

Personally I am ALL FOR COMPETITION. I have noted here before .... if I were Payne, I would have sent data to ALL the major pharmas with coccidiosis treatments and I would have done articles or interviews with animal groups pushing to have antibiotics removed from animal therapeutics. Enough dicking around. =)

But at same time I do realize ZIVO may be in a delicate position ... but at some point, if you think you have the breakthrough that you do ...... you need to turn up the gas and try to make best deal possible to commercialize. If all the eggs are in a single pharma's basket, then they get to dictate ...... If everyone gets the data and a chance to review and decide ...... then everyone knows the deal when everything shakes out if ZIVO has da goods or not and ZIVO can choose the best option to move forward. And if the other pharmas don't step up and have their products adversely impacted ... they had their shot at it.

In my book, chickens is only the tip of the iceberg. ZIVO toss in some additional data on other potential verticals, and a major pharma could get those things done much faster. And who knows, maybe one of them would just buy the company. Like glucosamine and animal joint health is a layup. Glucosamine I don't think really does much of anything, ZIVO on the other hand ..... they could do those tests easy. And animal joint supplement blows the rest away.

So I agree, it is time for major pharma to $hit or get off the pot with this. IMO ZIVO needs to turn up the gas bigtime. And at end of this time, need an offer on the table.

Amigo Mike

Ya, it's definitely the first test that is being funded by the potential partner that I can recall too. That in and of itself is a major positive change (as you mentioned).

This action makes it literally impossible to position again...as there is no way I'm chasing with such little volume and such huge spreads. I'd rather take my money to the casino and at least have some fun... 🙃

The threat of 3-4 months of more silence (aka, business as usual)...will likely be offset by the "hope for test results pending" again (like last year). This is where not being listed on an exchange and being on OTC is a hindrance...as it limits the volume potential outside of major news imo.

EDIT: Oh, and...if this is yet another positive test (which is highly probable given every test since the beginning of time has been positive other than the botched test last year)...announcing results without a deal again would be preposterous.

Kinda interesting that you cannot buy any size in this stock without moving it sharply. Insiders holding very tightly.
Looks like someone willing to part with 2000 shares at $11.55 but other than that it is 100 share lots across the board.

And I reestablished my $99.00 GTC offers that expired .... =)
Amigo Mike

This thing should be over $10 to stay today..... IMO

It is long past due getting past $10 but with a "GLOBAL LEADER" in animal pharma footing the bill to do this confirmation test ....... while not what we were looking for ...... ZIVO is in the door with a big boy who is forking up money to get involved.

Would like to see some more news from ZIVO .... on other fronts as well.

Guess this could be reason why someone been "nibbling" at the stock. No filing from Maggiore so I guess the prior jump was not him. Good news.

Amigo Mike

Can't say this is what I was looking for .... but also can't say that I'm surprised.

Also no indication in the PR as to whether this is a new animal pharma .... "A GLOBAL LEADER" ........ or the one already involved with the prior testing. Of course anyone can look up which animal pharmas offer ionosphere based coccidiosis treatments and vaccines ....... and draw up your short list. The names everyone knows .... including one that Payne used to be CEO of animal pharma division prior to acquisition.

Interesting information Funded by the major animal health company, the study focuses on the overall health and productivity of the birds under typical industry conditions, and compares administration of ZIVO’s product versus an ionophore-based treatment and versus an ionophore-based treatment combined with ZIVO’s product. The study also compares the benefits of ZIVO’s product combined with coccidiosis vaccine versus administration without the vaccine. Results from the study are expected to be available in September.
1. Positive - They are paying for it - I don't recall that any prior testing was solely funded by another company.
2. Negative - Another test. More time. Cone silence for another 3-4 months ?
3. How can we be assured this test is run properly with no screwups ?
4. Already did the confirmation study on the overall health and productivity.
5. New stuff - comparison to ionophore treatment ..... and a combo version of ZIVO/ionosphere treatment. I figure this component is beneficial and necessary given the likelihood of crossover and or combination of treatments vs a direct switch from ionsphere to ZIVO 100%. Big pharma still gotta have the answer and their hand in the pie even though they'd be licensed with the ZIVO offering. And of course nothing offered on what level of efficacy ZIVO would need to achieve relative to ionosphere treatment in order for this to be considered for licensing.

So, good news .... and not so good news .......

And so we wait .... again .....
Amigo Mike

What was the point of the last confirmatory study? Hopefully they don’t F this one up.

Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08 2024 - 8:00AM
Business Wire

ZIVO Bioscience, Inc. (NASDAQ: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces the initiation of a 42-day confirmatory study targeting coccidiosis in collaboration with a major global animal health company.

This new study aims to further validate the efficacy of ZIVO’s non-antibiotic, immune-modulating product designed for the prevention and treatment of coccidiosis in broiler chickens. Building upon the positive outcomes of previous trials, this study replicates real-world conditions to ensure the product's effectiveness in commercial poultry production environments.

“We are delighted to support a global leader in animal health as they perform this confirmatory study, which holds potential to accelerate commercialization of our innovative treatment. Coccidiosis costs the poultry industry more than $10 billion annually, and traditional treatments rely heavily on antibiotics and ionophores that have not seen significant innovation in over six decades,” said John Payne, Chairman and CEO of ZIVO Bioscience.

“This 42-day study is a significant step forward in our mission to provide sustainable, antibiotic-free solutions for the poultry industry. Our product represents a groundbreaking alternative designed to boost the immune response of broiler chickens without the adverse effects associated with legacy treatments. We are optimistic the results of this study will further support its market readiness,” he added.

Funded by the major animal health company, the study focuses on the overall health and productivity of the birds under typical industry conditions, and compares administration of ZIVO’s product versus an ionophore-based treatment and versus an ionophore-based treatment combined with ZIVO’s product. The study also compares the benefits of ZIVO’s product combined with coccidiosis vaccine versus administration without the vaccine. Results from the study are expected to be available in September.

About Coccidiosis

Coccidiosis is a protozoal disease that causes diarrhea, weight loss, decreased performance and increased mortality in poultry. This disease represents a significant economic challenge for the global poultry industry, as indicated by a 2020 study that estimated annual costs ranging from $10 billion to $17 billioni. Products for treating coccidiosis are mostly antibiotic- or ionophore-based, and no significant new commercial technology has been introduced in the past 60 years. The global poultry industry spends more than $1.5 billion annually on coccidiosis control, primarily using decades-old compounds that industry and consumers alike want to replace due to the risks of developing drug resistance. Coccidiosis is a common disease for chickens, especially among young chicks, and can be fatal or result in compromised digestion.

About ZIVO Bioscience

ZIVO Bioscience is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.

Ohhh, good...yet ANOTHER "42 day Confirmatory Study".

How many does it take? Feels like groundhog day around here. Seems we are fast approaching to "beginning our Bi-Annual Confirmatory Study" territory. lol

At least this time ZIVO isn't fronting the cost, but the "Major Global Animal Health Company" is...

https://ih.advfn.com/stock-market/NASDAQ/zivo-bioscience-ZIVO/stock-news/94157905/major-global-animal-health-company-launches-42-day

My bet is on a new Maggiore buy. Guess we'll see soon. That of course would be good news / bad news if it turns out to be the case. Good news ... insider buy. Bad news ... no news soon.

So far the bid still being maintained ....
$7.81 / $9.37

I'm somewhat surprised and still don't know why retail would buy it like yesterday with the cone of silence in place.

Amigo Mike

To me it looked like someone had $10 Grand and wanted in but didn't want to wait so they just hit the BUY button...

Easy come easy go.

Wasn't me playing with the stock or selling any of the open swing position I still have.

Amigo Mike

...and from $11 back to $7's with just a few hundred shares. Nutty.

LOL,

$11 ..... Hmmmmmm .....

5 MMs stacked at roughly $11.50ish area give or take a penny or 2.

Amigo Mike

LOL Weasel,

Funny you asked about my offers. I think I might have mentioned this before but to answer your question RE: Offer.

I actually had GTCs on all my accounts for ZIVO at $99.00. But just checked and the GTC orders expired a couple weeks ago .... so I will reestablish them. Don't want any shenanigans using my accounts even though I know it happens anyway. That's only a roughly $300 million valuation. Of course ... IMO .... with multiple verticals realized .... IMO it is worth more than that.

Amigo Mike

Personally,

I've no problem with the stock gaining $10 and .... hopefully ..... holding that new level. Double digits is a milestone.
But again wouldn't shock me if that is Maggiore buying although I would think that he can't given the EoQ at this point.

The Director and CFO awards are still bugging me. Excessive ...... unless ........

Amigo Mike

As you've previously mentioned, that GTSM market maker always seems to be involved in the 'shenanigans' with this ticker. ie-it appeared they were the ones tossing shares back and forth amongst themselves with those odd prints in the 3's/5's and then suddenly back up in the 7's the last few weeks (given it was typically just a few hundred shares and easy to accomplish).

Sellers stacking up that 11.50ish area now.

"Peculiar" action this morning to say the least, but again...just 1783 shares traded as of this post.

Agree,

Plus can't move any size even if you wanted too ...

I'm just waiting patiently. Have to wonder why someone is buying above recent market prices and 20% higher at $10 this morning. Of course .... IMO ... the company is much further along than it ever was before under Dahl and the price should already be well north of $10 just to get back to valuation prior to dismal 2023 fiasco ......... plus ..... we don't know where negotiations stand with animal pharma ........ so even though volume is minimal ...... gotta wonder.

Frankly wouldn't be shocked to see Form 4 in a couple days. LOL

And strange that now 2 bidders above $9 and some "offer stacking" around $11.50ish.
Amigo Mike

Yep...and current spread is $2.45 (9.10/11.55). That's untradeable in my book...

True,

I was trying to pick off shares in the low $5 range in past weeks but it isn't worth the time when there are so many other stocks to make bank on and ya can't buy much of anything to meaningfully trade anyway.

But someone continue to step up into upper $7 range anytime there is the slight bit of selling.
And just as I say it ..... buying above $8 and into the $9 range.

And now best offer $11.55 .... LOL
9.10x11.55

Pharma news right now would be fun to see what happens.

Amigo Mike

No idea what is going on with this thing right now, but given the anemic volume and the spreads (commonly $1-$2)...it is impossible to try and legitimately do anything with it.

PS- Amigo, is that your $71.28 offer out there with E-trade??? 🤪

LOL,

No one wants to pay above $8/share for this. Would be surprise to see upward movement without news occurring .... or in anticipation of news ..... but one can't anticipate what it hears nothing about ...... =)

Amigo Mike

Weasel,

I think your assertion is true. So far the stock is generally holding around the $8 level save a couple sells here and there. Someone still buying it back to $8 .... thus far. Given the tightly held nature of the stock I think that is a good sign that Payne is still working a pharma deal. Externally no reason for an outsider to buy it. No news. No info.

So we wait on the other shoe to drop. And like you ... I'm watching for clues as to the stock movement. The way these low floaters are popping off these days ..... a pharma deal from ZIVO could send this northward big time on release. Of course I would expect ZIVO to botch or blunt the release of that info as they always do ... if it happens of course. Remember that this is a novel approach for animal pharma. No change in this space for 6 decades. So a deal as we see not happening overnight. Encouraged by recent Maggiore buy and the stock generally maintianing level .........leads me to think things are still being worked given it's timing and the action.

Amigo Mike

More "good" news, ZIVO-ers...

Looking at a daily chart, if $7 becomes heavy...barring the unexpected...ZIVO appears to be starting its 'typical' slow death bleed into end of year as ALL VOLUME from 1/22/24 forward will be underwater. Selloff likely will not be as extreme as last year given there are no Armistice type holders, but slow, painful and annoying nonetheless.

This time is NOT different unless PROVEN it IS different...

Same as it ever was...

ZERO from ZIVO….I like it…shows promise!

Lmao

So much worthless noise here…for a stock that barely trades…sad really.

They have already stated algae production will not be ramped up until 2025. Expecting no major news until then. Why put a hundred million in R&D and then exit right when you can start producing large volumes? They need enough revenue to “keep the lights on” until then.

Amigo, the sale of the company would be the cleanest i.e. agree on some fair price for what ZIVO has compiled to date and put a value/price to it.

OR

Have a buyer(s) buy certain aspects of the company with rights to buy other parts of the company etc. Of course ZIVO could put a ROFR on so the buyer does not have to buy the whole company but has the right to if another buyer wants to buy the other part(s)

Gwinner,

It appears to me that Maggiore just bought shares in the open market so I'm not sure what the minimum timeframe is for the company to then announce material news.

That said, IMO, there could be as many as 3 different material events short term. You can probably figure out 1 or 2 of them ...... I think there could be a surprise item in there too.

I am standing pat with my open swing position in lieu of no information to the contrary and have already more than covered the cost and riding free. As noted previous, I am leaning towards a sale of the company at this point but a couple different things could happen. And I still think a fair price is multiples of the current price.

Amigo Mike

Albeit the volume was light but the buyer popped us above the 8's maybe a some newsy item might be getting ready to be dropped?

Interesting on a Friday to see some positive action and .... above $8 with the bid above $8 as well.

Albeit we are talking pocket change volume here. Nice to see though. Too bad still ZERO from ZIVO.

Amigo Mike

The question is who gonna buy it above $8 in lieu of zero from ZIVO ? Sellers showing more size again today.

Maybe new company slogan ...... ZERO from ZIVO !!

Amigo Mike